[MDGL] YoY Quarter Result on 30-Jun-2012 [#Q2]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
02-Aug-2012
Financial Year
2012
Quarter
30-Jun-2012 [#Q2]
Profit Trend
QoQ- 2.86%
YoY- -16.94%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Revenue 0 0 0 0 1,354 3,360 4,650 -
PBT -19,800 -22,286 -22,787 -14,620 -12,502 -9,074 -8,495,000 -63.57%
Tax 0 0 0 0 0 30 -41,958 -
NP -19,800 -22,286 -22,787 -14,620 -12,502 -9,074 -8,495 15.13%
Tax Rate - - - - - - - -
Total Cost 19,800 22,286 22,787 14,620 13,856 12,434 13,145 7.06%
Ratio Analysis
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
NP Margin 0.00 0.00 0.00 0.00 -923.34 -270.06 -182.69 -
Per Share
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
EPS -5.24 -8.29 -11.55 -8.88 -9.15 -7.87 -8.78 -8.23%
EPS Diluted -5.24 -8.29 -11.55 -8.88 -9.15 -7.87 -8.78 -8.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.